Public Alert No. 043/2026-NAFDAC Places Products Marketed by Mofus Nigeria Ltd on Watchlist Pending Regulatory Investigation
The National Agency for Food and Drug Administration and Control (NAFDAC) wishes to inform healthcare professionals, distributors, wholesalers, retailers, Patent and Proprietary Medicine Vendors (PPMVs), healthcare institutions, and the general public that products marketed by Mofus Nigeria Ltd have been placed on the NAFDAC Watchlist pending the outcome of an ongoing regulatory investigation. The decision […]
Public Alert No. 042/2026-Alert on the Seizure of Suspected Substandard and Falsified BPPL Artemether/Lumefantrine 80mg/480mg
The National Agency for Food and Drug Administration and Control (NAFDAC) is notifying healthcare providers, importers, distributors, retailers, Patent and Proprietary Medicine Vendors (PPMVs), and the general public of the seizure of a suspected Substandard and Falsified (SF) antimalarial medicine, Artemether/Lumefantrine 80mg/480mg, purportedly manufactured by Bandaram Pharma Packleh Ltd (BPPL), India. The product was intercepted […]
Public Alert No. 041/2026 – Alert on Suspected Counterfeit ORACIRE+ Toothpaste
The National Agency for Food and Drug Administration and Control (NAFDAC) is informing the public of the circulation of a suspected counterfeit toothpaste product, ORACIRE+ TOOTHPASTE, which is being distributed in Nigeria under the guise of the registered ORACARE+ Toothpaste. This follows a formal complaint and a market intelligence report regarding the widespread distribution of […]
